Rice Hall James & Associates, LLC Vanda Pharmaceuticals Inc. Transaction History

Rice Hall James & Associates, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $452,317 - $1.01 Million	-60,309 Closed	0 $0
Q4 2019 Jan 29, 2020	SELL	$12.38 - $17.47 $2,884 - $4,070	-233 Reduced 0.38%	60,309 $990,000
Q3 2019 Oct 30, 2019	BUY	$12.27 - $15.79 $19,816 - $25,500	1,615 Added 2.74%	60,542 $804,000
Q2 2019 Aug 01, 2019	BUY	$13.37 - $18.85 $40,337 - $56,870	3,017 Added 5.4%	58,927 $830,000
Q1 2019 May 01, 2019	BUY	$17.59 - $31.05 $310,393 - $547,908	17,646 Added 46.12%	55,910 $1.03 Million
Q4 2018 Feb 14, 2019	BUY	$18.97 - $31.47 $258,921 - $429,534	13,649 Added 55.45%	38,264 $1 Million
Q3 2018 Oct 25, 2018	SELL	$18.25 - $23.0 $1,971 - $2,484	-108 Reduced 0.44%	24,615 $565,000
Q2 2018 Aug 02, 2018	BUY	$13.95 - $19.15 $5,872 - $8,062	421 Added 1.73%	24,723 $471,000
Q1 2018 Apr 25, 2018	SELL	$14.05 - $20.2 $55,399 - $79,648	-3,943 Reduced 13.96%	24,302 $409,000
Q4 2017 Jan 23, 2018	BUY	$12.85 - $18.1 $4,150 - $5,846	323 Added 1.16%	28,245 $429,000
Q3 2017 Oct 30, 2017	BUY	$15.4 - $18.85 $429,998 - $526,329	27,922	27,922 $500,000

158

44.7M

64.8K

562K

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $244M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

Get notified when there are updates to the investment portfolio of Rice Hall James & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Rice Hall James & Associates, LLC with notifications on news.